ZA929355B - Expression of specific immunogens using viral antigens. - Google Patents

Expression of specific immunogens using viral antigens.

Info

Publication number: ZA929355B
Authority: ZA; South Africa
Prior art keywords: expression; viral antigens; specific immunogens; immunogens; specific
Prior art date: 1991-12-11

Application number

ZA929355A

Other languages

English (en)

Inventor

Paul Porwen Hung

Shaw-Guang Lin Lee

Narender Kumar Kalyan

Original Assignee

American Home Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-12-11

Filing date

1992-12-02

Publication date

1994-06-02

1992-12-02 Application filed by American Home Prod filed Critical American Home Prod

1994-06-02 Publication of ZA929355B publication Critical patent/ZA929355B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Biophysics (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Immunology (AREA)
Physics & Mathematics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

ZA929355A 1991-12-11 1992-12-02 Expression of specific immunogens using viral antigens. ZA929355B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US80510591A	1991-12-11	1991-12-11

Publications (1)

Publication Number	Publication Date
ZA929355B true ZA929355B (en)	1994-06-02

Family

ID=25190685

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA929355A ZA929355B (en)	1991-12-11	1992-12-02	Expression of specific immunogens using viral antigens.

Country Status (17)

Country	Link
US (1)	US5591823A (no)
EP (1)	EP0546787A3 (no)
JP (1)	JPH05262667A (no)
KR (1)	KR930013112A (no)
CN (1)	CN1073878A (no)
AU (1)	AU2981992A (no)
BR (1)	BR9204978A (no)
CA (1)	CA2084180A1 (no)
CZ (1)	CZ362692A3 (no)
FI (1)	FI925590L (no)
HU (2)	HUT65366A (no)
IL (1)	IL103928A0 (no)
MX (1)	MX9207113A (no)
NO (1)	NO924780L (no)
SK (1)	SK362692A3 (no)
TW (1)	TW239162B (no)
ZA (1)	ZA929355B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69333433T2 (de) *	1992-04-01	2004-12-02	The Rockefeller University	Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung
DE69332485T2 (de) *	1992-08-11	2003-11-13	The President And Fellows Of Harvard College, Cambridge	Immunmodulierende peptide
WO1995007099A1 (fr) *	1993-09-09	1995-03-16	The Nisshin Oil Mills, Ltd.	Vaccin et procede pour sa production
US5762939A (en)	1993-09-13	1998-06-09	Mg-Pmc, Llc	Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
EP2374894B1 (en) *	1993-09-13	2014-09-17	Protein Sciences Corporation	A method for producing influenza hemagglutinin multivalent vaccines
ES2370937T3 (es)	1993-09-13	2011-12-23	Protein Sciences Corporation	Un método para producir vacunas antigripales polivalentes a base de hemaglutinina.
US6300090B1 (en)	1994-07-29	2001-10-09	The Rockefeller University	Methods of use of viral vectors to deliver antigen to dendritic cells
ATE386812T1 (de) *	1995-05-26	2008-03-15	Mg Pmc Llc	Methode für die produktion von multivalenten influenza hämagglutinin vakzinen
US7659119B2 (en)	1996-02-12	2010-02-09	Argos Therapeutics, Inc.	Method and compositions for obtaining mature dendritic cells
WO1998048834A1 (en) *	1997-04-30	1998-11-05	The Mount Sinai School Of Medicine Of The City University Of New York	Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
EP2058389B1 (en)	1997-10-27	2016-05-18	Rockefeller University	Defined dendritic cell maturation medium comprising TNF-alpha, IL-1beta, IL-6
US6602709B1 (en)	1998-02-20	2003-08-05	The Rockefeller University	Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
WO2002026252A1 (fr) *	2000-08-10	2002-04-04	Tsinghua University	Vaccin contre le virus de la grippe et son procede de preparation
KR100836519B1 (ko)	2000-09-11	2008-06-12	다우 글로벌 테크놀로지스 인크.	무공압 주행 타이어 지지부
US20040203084A1 (en) *	2003-04-10	2004-10-14	Doug Levinson	Profiling conformational variants, antibody compositions and methods of using the same
KR20080027777A (ko) *	2005-06-01	2008-03-28	배리에이션 바이오테크놀로지스 아이엔씨.	펩티드기초 인플루엔자 백신 제제
AU2007207544A1 (en)	2006-01-17	2007-07-26	Health Research, Inc.	Heteroduplex tracking assay
TWI438207B (zh) *	2007-02-21	2014-05-21	Oncotherapy Science Inc	表現腫瘤相關抗原之癌症的胜肽疫苗
EP2012122A1 (en) *	2007-07-06	2009-01-07	Medigene AG	Mutated parvovirus structural proteins as vaccines
US10004799B2 (en)	2007-08-27	2018-06-26	Longhorn Vaccines And Diagnostics, Llc	Composite antigenic sequences and vaccines
EP3058954B1 (en)	2007-08-27	2017-03-01	Longhorn Vaccines and Diagnostics, LLC	Immunogenic compositions and methods
TW201008574A (en)	2008-08-19	2010-03-01	Oncotherapy Science Inc	INHBB epitope peptides and vaccines containing the same
CN104086625B (zh)	2008-10-22	2016-08-31	肿瘤疗法科学股份有限公司	Rab6kifl/kif20a表位肽及包含它的疫苗
CN101708442B (zh) *	2009-09-04	2011-08-24	山东中惠仪器有限公司	全自动标准气体配制装置
ES2625406T3 (es)	2010-03-25	2017-07-19	Oregon Health & Science University	Glicoproteínas de CMV y vectores recombinantes
PL2691530T3 (pl)	2011-06-10	2019-02-28	Oregon Health & Science University	Glikoproteiny i rekombinowane wektory CMV
US20130189754A1 (en)	2011-09-12	2013-07-25	International Aids Vaccine Initiative	Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en)	2011-10-27	2016-08-02	International Aids Vaccine Initiative	Viral particles derived from an enveloped virus
EP2679596B1 (en)	2012-06-27	2017-04-12	International Aids Vaccine Initiative	HIV-1 env glycoprotein variant
EP2848937A1 (en)	2013-09-05	2015-03-18	International Aids Vaccine Initiative	Methods of identifying novel HIV-1 immunogens
EP2873423B1 (en)	2013-10-07	2017-05-31	International Aids Vaccine Initiative	Soluble hiv-1 envelope glycoprotein trimers
EP3069730A3 (en)	2015-03-20	2017-03-15	International Aids Vaccine Initiative	Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en)	2015-03-23	2016-09-28	International Aids Vaccine Initiative	Soluble hiv-1 envelope glycoprotein trimers
US10063211B2 (en) *	2016-02-03	2018-08-28	Qualcomm Incorporated	Compact bypass and decoupling structure for millimeter-wave circuits
CA3012703A1 (en)	2016-02-03	2017-08-10	Cg Discovery, Inc.	Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0339504A3 (en) *	1988-04-26	1990-09-12	The Du Pont Merck Pharmaceutical Company	Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5166057A (en) *	1989-08-28	1992-11-24	The Mount Sinai School Of Medicine Of The City University Of New York	Recombinant negative strand rna virus expression-systems
EP0492920A1 (en) *	1990-12-24	1992-07-01	Merck & Co. Inc.	Chimaeric influenza-HIV vaccine

1992
- 1992-11-30 CA CA002084180A patent/CA2084180A1/en not_active Abandoned
- 1992-11-30 IL IL103928A patent/IL103928A0/xx unknown
- 1992-12-01 JP JP4321768A patent/JPH05262667A/ja active Pending
- 1992-12-02 ZA ZA929355A patent/ZA929355B/xx unknown
- 1992-12-02 AU AU29819/92A patent/AU2981992A/en not_active Abandoned
- 1992-12-07 TW TW081109778A patent/TW239162B/zh active
- 1992-12-07 EP EP19920311146 patent/EP0546787A3/en not_active Withdrawn
- 1992-12-09 MX MX9207113A patent/MX9207113A/es unknown
- 1992-12-09 KR KR1019920023656A patent/KR930013112A/ko not_active Application Discontinuation
- 1992-12-09 FI FI925590A patent/FI925590L/fi not_active Application Discontinuation
- 1992-12-10 BR BR9204978A patent/BR9204978A/pt not_active Application Discontinuation
- 1992-12-10 SK SK3626-92A patent/SK362692A3/sk unknown
- 1992-12-10 CZ CS923626A patent/CZ362692A3/cs unknown
- 1992-12-10 CN CN92113703A patent/CN1073878A/zh active Pending
- 1992-12-10 NO NO92924780A patent/NO924780L/no unknown
- 1992-12-11 HU HU9203931A patent/HUT65366A/hu unknown
1993
- 1993-12-17 US US08/169,813 patent/US5591823A/en not_active Expired - Lifetime
1995
- 1995-06-27 HU HU95P/P00456P patent/HU211548A9/hu unknown

Also Published As

Publication number	Publication date
TW239162B (no)	1995-01-21
MX9207113A (es)	1994-05-31
BR9204978A (pt)	1993-06-15
CA2084180A1 (en)	1993-06-12
FI925590L (fi)	1993-06-12
EP0546787A2 (en)	1993-06-16
HU211548A9 (en)	1995-12-28
US5591823A (en)	1997-01-07
HUT65366A (en)	1994-05-02
IL103928A0 (en)	1993-04-04
HU9203931D0 (en)	1993-04-28
CN1073878A (zh)	1993-07-07
JPH05262667A (ja)	1993-10-12
AU2981992A (en)	1993-06-17
CZ362692A3 (en)	1994-02-16
SK362692A3 (en)	1995-11-08
KR930013112A (ko)	1993-07-21
NO924780L (no)	1993-06-14
NO924780D0 (no)	1992-12-10
FI925590A0 (fi)	1992-12-09
EP0546787A3 (en)	1994-06-01

Publication	Publication Date	Title
ZA929355B (en)	1994-06-02	Expression of specific immunogens using viral antigens.
OA09200A (en)	1992-06-30	Vaccines for malaria.
AU4325089A (en)	1990-04-02	Viral vaccines
GR3025184T3 (en)	1998-02-27	Vaccine composition containing adjuvants.
HU9302645D0 (en)	1994-01-28	Vaccine
HU9202436D0 (en)	1992-12-28	Vaccines
EP0666752A4 (en)	1996-09-11	THERAPEUTIC MICROEMULSIONS.
EP0652770A4 (en)	1996-05-29	ORAL ADMINISTRATION OF ANTIGENS.
HUP9601466A2 (en)	1997-03-28	Adjuvants for viral vaccines
HUP9601462A2 (en)	1997-03-28	Adjuvants for viral vaccines
LTIP335A (en)	1995-01-31	Vaccine for human immunodeficiency virus
IT8820163A0 (it)	1988-04-11	Accoppiamento elettromagnetico per dolce avviamento.
EP0595970A4 (en)	1995-05-31	IMPROVED VACCINE.
AU2370592A (en)	1993-02-23	Epitopes of the env protein of the hepatitis c virus
EP0266401A4 (en)	1988-09-28	VACCINE.
EP0344211A4 (en)	1990-03-12	MONOCLONAL ANTIBODIES IN VACCINE COMPOSITIONS.
ZA939564B (en)	1994-08-15	Vaccines.
GB9020799D0 (en)	1990-11-07	Viral vaccines
GB9104903D0 (en)	1991-04-24	Viral vaccines
ZA93236B (en)	1993-08-16	Babesial rhoptry antigens.
GB8712042D0 (en)	1987-06-24	Virus & vaccine
ZA916490B (en)	1992-04-29	Footrot vaccine
GB9117602D0 (en)	1991-10-02	Novel antigens
GB9122301D0 (en)	1991-12-04	Novel antigens
IE880242L (en)	1988-07-30	Hepatitis b virus antigens.